Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,294.50 -12.67 -0.08%
S&P 500 1,650.51 -4.84 -0.29%
Nasdaq 3,459.42 -3.88 -0.11%
Ticker Volume Price Price Delta
STOXX 50 2,776.78 -58.23 -2.05%
FTSE 100 6,696.79 -143.48 -2.10%
DAX 8,351.98 -178.91 -2.10%
Ticker Volume Price Price Delta
Nikkei 14,550.80 +66.80 0.46%
Hang Seng 22,624.20 -45.47 -0.20%
S&P/ASX 200 4,962.70 -99.75 -1.97%
  • Exchange: London
  • Sector: Consumer, Non-cyclical
  • Industry: Healthcare-Products
  • Sub-Industry: Diagnostic Kits

Akers Biosciences Inc

+ Add to Watchlist

AKR:LN

1.4750 GBp 0.00000.00%

As of 11:30:00 ET on 05/23/2013.

Company Profile for Akers Biosciences Inc (AKR)

Akers Biosciences, Inc. develops diagnostic kits. The Company produces kits that screen blood, urine, or saliva to rapidly diagnose HIV, hepatitis B, lyme disease, sexually transmitted diseases, mononucleosis, rheumatoid arthritis, hepatitis C, malaria and the presence of alcohol and several drugs. The kits can be used in clinics, hospitals, and doctors' offices.

Contact Information

Akers Biosciences Inc

201 Grove Road
Thorofare, NJ 08086
United States
Phone: 1-856-848-2116
Fax: 1-856-848-0269

Key Executives for Akers Biosciences Inc (AKR)

Raymond F Akers JrChairmanThomas A NicolettePresident/CEO
Patrice Laterra McMorrowVP:MarketingGary RauchController

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil